C.D. Cukier

Molecular basis of FIR-mediated c-myc transcriptional control

C.D. Cukier, David Hollingworth, Stephen R. Martin et al. · Nature Structural & Molecular Biology · 2010 · 64 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

The AEROPATH project targeting<i>Pseudomonas aeruginosa</i>: crystallographic studies for assessment of potential targets in early-stage drug discovery

L. Moynié, R. Schnell, S.A. McMahon et al. · Acta Crystallographica Section F Structural Biology and Crystallization Communications · 2012 · 40 citations · Full text

Pharmacy, Microbiology, Pharmacology +15

Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity

Edoardo Cellupica, Gianluca Caprini, Paola Cordella et al. · Journal of Biological Chemistry · 2022 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-acyl-ACP Reductase from <i>Pseudomonas aeruginosa</i>

C.D. Cukier, Anthony G. Hope, Ayssar A. Elamin et al. · ACS Chemical Biology · 2013 · 37 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors

Giovanni Sandrone, C.D. Cukier, Karol Źrubek et al. · ACS Medicinal Chemistry Letters · 2021 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10